Lobbying

Pride Mobility Products's latest lobbying report covers Q2 2026, at $35K. The four quarters Q4 2025–Q3 2026 total $95K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.

Pride Mobility Products

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$95K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Pride Mobility Products lobbying by quarter
Pride Mobility Products lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$35K1
Q2 2024$35K1
Q3 2024$30K1
Q4 2024$30K1
Q1 2025$30K1
Q2 2025$30K1
Q3 2025$30K1
Q4 2025$30K1
Q1 2026$30K1
Q2 2026$35K1
Q3 2026$00

By issue

  • Medicare and Medicaid$515K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
In-housePride Mobility Products$515K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/14for Q2In-house$35K
04/09for Q1In-house$30K
01/16for Q4 2025In-house$30K
25/11/07for Q3 2025In-house$30K
25/08/05for Q2 2025In-house$30K
25/05/05for Q1 2025In-house$30K
25/03/11for Q4 2024In-house$30K
25/01/28for Q4 2024In-house$30K
24/10/22for Q3 2024In-house$30K
24/07/15for Q2 2024In-house$35K
24/04/15for Q1 2024In-house$35K
24/01/25for Q4 2023In-house$40K
23/11/20for Q3 2023In-house$40K
23/07/17for Q2 2023In-house$40K
23/05/03for Q1 2023In-house$40K
23/01/16for Q4 2022In-house$40K